Literature DB >> 10737594

p27Kip1 expression by contact inhibition as a prognostic index of human glioma.

T Fuse1, M Tanikawa, M Nakanishi, K Ikeda, T Tada, H Inagaki, K Asai, T Kato, K Yamada.   

Abstract

The clinical manifestations of human glioma are known to be diverse, ranging from aggressive growth and invasion to apparent dormancy; however, the molecular mechanism underlying this diversity has been largely unexplored. In the present study, we characterized four human glioma cell lines, T98G, A172, U251, and NAC6, each of which has distinct growth properties. A172 and U251 cells continue to grow after confluency, whereas the growth of T98G and NAC6 cells is contact inhibited. Northern and western blot analyses revealed that at high cell density, the expression of p27Kip1 cyclin-dependent kinase inhibitor was dramatically enhanced at both the RNA and the protein levels in T98G and NAC6 cells but not in A172 or U251. These facts together with the finding that overexpression of p27Kip1 caused G1 arrest in A172 and T98G cells suggest that the induction of p27Kip1 represents an important determinant of growth at high cell density. Immunohistochemical analyses of 42 primary gliomas revealed an inverse correlation between the level of p27 protein and the Ki-67 proliferative index. Kaplan-Meier plots demonstrated that a low level of p27 in tumors is associated with decreased overall survival. Thus, disrupted regulation of p27 expression at high cell density may play an important role in determining the clinical behavior of human gliomas as well as the prognosis for glioma patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10737594     DOI: 10.1046/j.1471-4159.2000.0741393.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

Review 1.  Cip/Kip cell-cycle inhibitors: a neuro-oncological perspective.

Authors:  T G Mainprize; M D Taylor; J T Rutka; P B Dirks
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

2.  YAP-Mediated Recruitment of YY1 and EZH2 Represses Transcription of Key Cell-Cycle Regulators.

Authors:  Sany Hoxha; Alyssa Shepard; Scott Troutman; Huitian Diao; Joanne R Doherty; Michalina Janiszewska; Robert M Witwicki; Matthew E Pipkin; William W Ja; Michael S Kareta; Joseph L Kissil
Journal:  Cancer Res       Date:  2020-05-14       Impact factor: 12.701

3.  Pleomorphic xanthoastrocytomas: immunohistochemistry, grading and clinico-pathologic correlations. An analysis of 34 cases from a single Institute.

Authors:  A Korshunov; A Golanov
Journal:  J Neurooncol       Date:  2001-03       Impact factor: 4.130

4.  Scatter factor/hepatocyte growth factor stimulation of glioblastoma cell cycle progression through G(1) is c-Myc dependent and independent of p27 suppression, Cdk2 activation, or E2F1-dependent transcription.

Authors:  Kevin A Walter; Mir Ahamed Hossain; Carey Luddy; Nidhi Goel; Thomas E Reznik; John Laterra
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

5.  Proteasome inhibitors induce growth inhibition and apoptosis in myeloma cell lines and in human bone marrow myeloma cells irrespective of chromosome 13 deletion.

Authors:  Ivana Zavrski; Cord Naujokat; Kathrin Niemöller; Christian Jakob; Ulrike Heider; Corinna Langelotz; Claudia Fleissner; Jan Eucker; Kurt Possinger; Orhan Sezer
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-08       Impact factor: 4.553

Review 6.  The role of cell differentiation in controlling cell multiplication and cancer.

Authors:  Karl-Hartmut von Wangenheim; Hans-Peter Peterson
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-15       Impact factor: 4.553

7.  Hypersensitivity to contact inhibition provides a clue to cancer resistance of naked mole-rat.

Authors:  Andrei Seluanov; Christopher Hine; Jorge Azpurua; Marina Feigenson; Michael Bozzella; Zhiyong Mao; Kenneth C Catania; Vera Gorbunova
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-26       Impact factor: 11.205

8.  Cell density-dependent inhibition of epidermal growth factor receptor signaling by p38alpha mitogen-activated protein kinase via Sprouty2 downregulation.

Authors:  Aneta Swat; Ignacio Dolado; Jose Maria Rojas; Angel R Nebreda
Journal:  Mol Cell Biol       Date:  2009-04-13       Impact factor: 4.272

9.  Immunohistochemical markers for prognosis of ependymal neoplasms.

Authors:  Andrey Korshunov; Andrey Golanov; Valery Timirgaz
Journal:  J Neurooncol       Date:  2002-07       Impact factor: 4.130

10.  Immunohistochemical markers for prognosis of anaplastic astrocytomas.

Authors:  Andrey Korshunov; Andrey Golanov; Regina Sycheva
Journal:  J Neurooncol       Date:  2002-07       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.